###### Article summary

Article focus
=============

-   Myocardial infarction (MI) is often followed by mental health problems such as depression, anxiety and low mental health status.

-   Mounting evidence indicates that depression and anxiety after MI increase the risk of adverse long-term outcome. No previous studies have examined the association between mental health status after MI and outcome, independent of depression and anxiety.

-   This study examines the association between mental health status after first-time MI and new cardiovascular events or death when taking into account depression and anxiety as well as clinical, sociodemographic and behavioural risk factors.

Key messages
============

-   During the 3 years after MI, patients with the lowest mental health status had an almost 50% risk of new cardiovascular events or death.

-   Low mental health status after MI was a strong predictor of new cardiovascular events or death, independent of depression, anxiety and clinical, sociodemographic and behavioural risk factors.

Strengths and limitations of this study
=======================================

-   The major strengths of this study are its population-based nature and the homogeneous study population. The response rate was reasonably high, and information on outcome was collected without loss to follow-up.

-   We were able to take into account important mediators such as depression, anxiety and potential behavioural mediators such as physical activity. However, we cannot rule out the possibility of residual confounding.

Introduction {#s1}
============

Myocardial infarction (MI) is a severe life event followed by an increased risk of mental health problems such as depression,[@R1] anxiety[@R2] and low mental health status.[@R3] Several studies have shown that depression[@R4] and anxiety[@R2] after MI are associated with a higher risk of cardiovascular events and death, but much less is known about the impact of broader measures of mental health. Mental health status is a generic and broad measure of mental health, which may be useful as a tool to quantify important prognostic aspects of mental health not captured by the more disease-specific measures of depression and anxiety. Four studies[@R5; @R6; @R7; @R8] have investigated the association between mental health status following MI and prognosis. All these have found that low mental health status was significantly associated with increased risk of adverse outcome, independent of clinical risk factors. However, since none of the former studies adjusted for depression or anxiety, it remains unknown whether mental health status in itself adds unique knowledge about the prognosis.

Our aim was to examine the association between mental health status and new cardiovascular events or death in patients with first-time MI when taking into account depression, anxiety, and clinical, sociodemographic and behavioural risk factors.

Methods {#s2}
=======

We conducted a population-based cohort study comprising people in the Central Denmark Region (1 250 000 inhabitants) with a first-time MI based on data from nationwide registers and questionnaires.

Participants {#s2a}
------------

We consecutively invited all patients discharged from hospital with a first-time MI from 1 January 2009 to 31 December 2009. The establishment of the cohort is described in detail elsewhere.[@R9] Data on patients discharged with MI (in accordance with the International Classification of Diseases (ICD-10) code I21)[@R10] were received from the Danish National Patient Register on a monthly basis. Patients who had been discharged with MI between 1994 and 2008 were excluded to identify first-time cases. Information on name, address and vital status was obtained from the Civil Registration System,[@R11] which also provided the unique personal identification number used to link data between the registers and questionnaires.

Data collection {#s2b}
---------------

A pilot-tested hard-copy questionnaire was sent to all participants 12--14 weeks after their discharge from hospital, and non-responders received two reminders.[@R9] The study was approved by the Danish Data Protection Agency (J.nr. 2009-41-3018), the Scientific Research Evaluation Committee of the Danish Academy of General Practitioners (ref. no. 03-2009), and written informed consent was obtained from all participants.

Mental health status {#s2c}
--------------------

Mental health status was measured using the Mental Component Summary (MCS) score from the validated Danish version of the Short-Form 12 V.2 Health Survey (SF-12).[@R12; @R13; @R14] SF-12 consists of 12 items, and the MCS score mainly comprises the six mental items ('Vitality', 'Role-Emotional' (2 items), 'Social Function' and 'Mental Health' (2 items)), but the six physical items are also included in the computation.[@R12] The SF-12 scores were calculated following the norm-based scoring algorithm[@R12] using weights derived from confirmatory factor analysis.[@R15] The MCS score is thus linearly transformed in a way that allows comparison with the mean score (50) and the SD (10) in the general US population in 1998.[@R12] The MCS has demonstrated good construct validity.[@R15] The wording of the mental health status items can be found in the supplemental material (see online supplementary figure 1).

Depression and anxiety {#s2d}
----------------------

We assessed depression and anxiety symptoms using the Hospital Anxiety and Depression Scale (HADS).[@R16] Participants were categorised as having anxiety or depression if they had a score of ≥8 on the HADS-A scale or the HADS-D scale. The HADS was designed to be valid in clinical populations with symptoms of physical disease and hence leaves out items that may be endorsed by physical rather than mental states.[@R16] [@R17] It has formerly been validated in MI patients[@R18] [@R19] and has proven to have satisfactory reliability (HADS-A and HADS-D Cronbach\'s α≈0.80).[@R18] [@R20] Among MI patients, a HADS-D≥8 identified possible cases of depression with a sensitivity of 65% and a specificity of 90% (compared with a diagnosis of depression based on a Structured Clinical Interview for DSM-IV).[@R19] Among acute coronary syndrome patients, a HADS-A≥8 identified possible cases of anxiety with a sensitivity of 91% and a specificity of 61% (compared with a diagnosis of generalised anxiety disorder based on a structured clinical interview for DSM-IV).[@R21]

Comorbidity and cardiac disease severity {#s2e}
----------------------------------------

Information on comorbidity was retrieved from the Danish National Patient Register,[@R22] the Danish National Diabetes Register,[@R23] and the prescription database covering the entire Central Denmark Region.[@R24] The Danish National Patient Register provided information on stroke (ICD-10: I61, I63, I64), transient cerebral ischaemic attack (ICD-10: DG45, DG46), heart failure (ICD-10: I11.0, I13.0, I13.2, I42.0, I42.6, I42.7, I42.9, I50.0, I50.1, I50.9), and revascularisation (ICD-10: KFN, KFW) from 1994 to 2008. The Danish National Diabetes Register provided information on diabetes mellitus from 1990 to 2008 according to an algorithm developed on the basis of information from four nationwide registers.[@R23] The prescription database provided information on all reimbursed drugs according to the Anatomical Therapeutic Chemical Classification System (ATC), dispensing dates and the total number of tablets dispensed. Participants were categorised with hypertension if they had redeemed prescriptions for at least two classes of antihypertensive drugs (ATC: C02A-D, C02 L, C03A-B, C03D-E, C03X, C04, C05, C07, C08, C09) 0--180 days before the index MI. Participants were categorised with depression before MI if they had redeemed a prescription for an antidepressant (ATC: N06A) 0--180 days before the index MI. Participants were categorised with severe mental disorder if they had redeemed a prescription for antipsychotics (ATC: N05A) 0--180 days before the index MI.

Cardiac disease severity was measured by the British Medical Research Council (MRC) dyspnoea score, a self-report instrument.[@R25] A score ≥3 has been shown to provide a simple and valid method for predicting overall mortality.[@R26]

Health behaviour, healthcare interventions and sociodemographics {#s2f}
----------------------------------------------------------------

Data on smoking, alcohol use, physical activity, intake of fruit and vegetables, intake of fish, intake of fish oil supplement, height and weight (body mass index=weight (kg) per height (m^2^)) were self-reported and classified according to the general recommendations from the Danish National Board of Health.[@R9] To assess physical activity, we asked, "How many days per week are you generally physically active for at least 30 minutes per day? You may include any physical activity at work or in your spare time that makes your pulse rate increase". Response options were from zero days to every day per week. Physical activity was computed as a continuous variable (days/week).

We defined cardiac rehabilitation[@R27] [@R28] in the questionnaire and asked whether they had participated in hospital-based phase two cardiac rehabilitation. Those who responded "yes, and I took part" were classified as 'participants', whereas those who responded "yes, but I didn\'t take part" or "no" were classified as 'non-participants'.[@R9]

Drug prescription data were obtained from the prescription database.[@R24] Data on aspirin (ATC: B01AC06), clopidogrel (ATC: B01AC04), statins (ATC: C10AA), β-blockers (ATC: C07), ACE-inhibitors/angiotensin 2 receptor blockers (ATC: C09), furosemide (ATC: C03C), aldosterone antagonists (ATC: C03D) and antidepressants (ATC: N06A) were collected. We calculated whether the participant had tablets available on the day that we sent the questionnaire (the number of tablets on the last redeemed prescription before the questionnaire was sent ≥ the number of days to the questionnaire was sent) and defined the participant as 'receiving treatment' if tablets were available. We defined the participant as 'receiving secondary prophylactic medication' if the participant was receiving treatment with three or more of the following drugs: aspirin, clopidogrel, statins and β-blockers. We defined the participant as 'receiving heart failure medication' if the participant was receiving treatment with furosemide or aldosterone antagonists.

Data on age at MI and sex were obtained from the Civil Registration System.[@R11] Each participant\'s sociodemographic characteristics (cohabitation status, education, labour market status) from the year before MI (2008) were retrieved from the Danish Integrated Database for Labour Market Research.[@R29]

Cardiovascular events and death {#s2g}
-------------------------------

Outcome events were measured as a composite endpoint comprising new cardiovascular events (MI, heart failure, stroke or transient ischaemic attack) and all-cause mortality. Information on outcomes was collected from baseline (the day we sent the questionnaire) to the last day of follow-up (31 July 2012). The Danish National Patient Register[@R22] provided information on cardiovascular events. Vital status (dead or alive) was obtained from the Civil Registration System.[@R11]

Statistical analysis {#s2h}
--------------------

Neither natural thresholds nor clinically-based thresholds are defined for the MCS score, so we divided the participants into quartiles according to their score (first quartile had the lowest score; fourth quartile had the highest score). This categorisation was done to enhance clinical interpretability and to evaluate a possible dose--response relationship.

In order to address the potential risk of selection bias, we used antidepressant consumption as a proxy for depression and calculated HRs for the association between antidepressant consumption and new cardiovascular events or death for both participants and non-participants.

The association between baseline characteristics and MCS score was assessed using χ^2^ statistics for categorical variables and analysis of variance for continuous variables, or Kruskal-Wallis tests when the conditions for analysis of variance were not fulfilled.

We calculated the event-free survival time as the time from 3 months after MI (baseline evaluation of mental health status) to the first cardiovascular event or death. If no event or death occurred, the participant was censored on 31 July 2012. Two persons emigrated during the time of follow-up, and they were censored on the day of their emigration. Owing to the use of nationwide registers, we had complete follow-up of all participants.

The unadjusted association between mental health status and new cardiovascular events or death was presented graphically with Kaplan-Meier curves. The cumulative incidence 3 years after MI was estimated using the cumulative hazards function, and identical incidence was tested using the log-rank test.

The risk of cardiovascular events or death associated with mental health status was compared using the Cox proportional hazards regression model. The covariates for the multivariate model (age, sex, cohabitation status, education, labour market status, cardiac disease severity, history of stroke, diabetes mellitus, heart failure, secondary prophylactic medication, smoking status, physical activity, depression and anxiety) were chosen on the basis of previous studies. To check for multicollinearity between depression/anxiety symptoms and mental health status, we calculated the variance inflation factor, which was 1.5. Values above 10 indicate multicollinearity.[@R30] We evaluated whether the HRs of mental health status following MI varied by subgroups by testing for interaction using the Wald test in an age-adjusted model, and the results are presented in a forest plot. Too few outcome events were available to test for interaction in quartiles, so we tested it in a dichotomised (median cut) model. We excluded variables with less than five events in a subgroup.

Finally, we calculated HRs for the association between each of the mental health status items (continuous; per one-point lower item score) and the outcome.

No variable had more than 0.3% missing data, except body mass index (for which 2.5% data were missing) and education (for which 3.3% data were missing), and analyses were performed on complete data only. p\<0.05 was considered statistically significant.

Results {#s3}
=======

Participant characteristics {#s3a}
---------------------------

Among a total of 1288 eligible patients with first-time MI, 880 (68.3%) completed SF-12, and the mean MCS score was 44.9 (SD 11.5). Non-participants were more often women, older and had fewer socioeconomic resources and more comorbid conditions than participants (see [online supplementary table A](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2013-003045/-/DC1)). The estimates of the association between antidepressant consumption and new cardiovascular events or death in participants, HR 1.55 (95% CI 1.12 to 2.14) and in non-participants, HR 1.46 (1.01 to 2.10), were similar. Compared to participants with a higher mental health status, the participants with the lowest mental health status (first quartile, [table 1](#BMJOPEN2013003045TB1){ref-type="table"}) were impaired in a range of variables; for example, symptoms of depression and anxiety, cardiac disease severity, comorbidity, socioeconomic resources and health behaviour.

###### 

Baseline characteristics of 880 patients with first-time myocardial infarction in 2009 by quartiles\* of mental health status (Mental Component Summary score from the Short-Form 12 V.2)

                                                        Baseline MCS Score                                                               
  ----------------------------------------------------- -------------------- ------------------- ------------------- ------------------- ---------
  Self-reported health‡                                                                                                                  
   Mental health status (MCS score)§, mean (range)      28.8 (11.1--37.2)    42.2 (37.2--47.0)   51.0 (47.0--54.5)   57.7 (54.5--60.8)   \<0.001
   HADS-A/D ≥8, No. (%)                                 152 (69.7)           79 (36.07)          22 (10.0)           2 (0.91)            \<0.001
  Sociodemographic characteristics                                                                                                       
   Age, years, mean (SD)                                68.9 (12.4)          68.4 (12.3)         65.6 (11.2)         64.5 (10.0)         \<0.001
   Male sex, N (%)                                      120 (54.6)           138 (62.7)          177 (80.5)          173 (78.6)          \<0.001
   Cohabitation status, living alone, N (%)¶            94 (42.7)            82 (37.3)           55 (25.0)           47 (21.4)           \<0.001
  Education, N (%)¶                                                                                                                      
   \<10 years                                           114 (53.3)           105 (50.2)          85 (39.7)           76 (35.5)           
   10--12 years                                         76 (35.5)            81 (38.8)           99 (46.3)           101 (47.2)          
   \>12 years                                           24 (11.2)            23 (11.0)           30 (14.0)           37 (173)            0.004
  Labour market status, N (%)¶                                                                                                           
   Working                                              50 (22.7)            70 (31.8)           99 (45.0)           103 (46.8)          
   Pension                                              136 (61.8)           123 (55.9)          105 (47.7)          107 (48.6)          
   Out of the work force                                34 (15.5)            27 (12.3)           16 (7.3)            10 (4.6)            \<0.001
  Health status‡                                                                                                                         
   Body mass index, mean (SD)                           26.5 (5.1)           26.3 (4.8)          26.8 (4.5)          26.9 (4.5)          0.626
  Comorbid conditions, N (%)\*\*                                                                                                         
   Hypertension††                                       88 (40.0)            75 (34.1)           54 (24.6)           54 (24.6)           \<0.001
   Stroke                                               21 (9.6)             16 (7.3)            7 (3.2)             5 (2.3)             0.002
   TCI                                                  12 (5.5)             3 (1.4)             3 (1.4)             10 (4.6)            0.021
   Revascularisation                                    37 (16.8)            16 (7.3)            12 (5.5)            15 (6.8)            \<0.001
   Heart failure                                        16 (7.3)             4 (1.8)             4 (1.8)             4 (1.8)             \<0.001
   Diabetes mellitus                                    51 (23.2)            38 (17.3)           24 (10.9)           21 (9.6)            \<0.001
   Depression‡‡                                         44 (20.0)            21 (9.6)            11 (5.0)            9 (4.1)             \<0.001
  Cardiac disease severity‡                                                                                                              
   MRC dyspnoea score ≥3, N (%)                         110 (50.2)           45 (20.5)           21 (9.6)            3 (1.4)             \<0.001
  Medication use, N (%)‡                                                                                                                 
   Aspirin                                              166 (75.5)           168 (76.4)          173 (78.6)          186 (84.6)          0.086
   Clopidogrel                                          159 (72.3)           164 (74.6)          173 (78.6)          184 (83.6)          0.025
   β-Blocker                                            174 (79.1)           181 (82.3)          178 (80.9)          180 (81.8)          0.837
   Statin                                               169 (76.8)           184 (83.6)          190 (86.4)          195 (88.6)          0.005
   ACE-inhibitors/AT-II-receptor block                  111 (50.5)           111 (50.5)          107 (48.6)          100 (45.5)          0.689
   Furosemide/aldosterone antagonist                    93 (42.3)            64 (29.1)           35 (15.9)           27 (12.3)           \<0.001
   Antidepressants                                      53 (24.1)            24 (10.9)           9 (4.1)             8 (3.6)             \<0.001
   Secondary prophylactic medication                    146 (66.4)           160 (72.7)          162 (73.6)          166 (75.5)          0.163
  Potential behavioural mediators‡                                                                                                       
   Alcohol consumption \>14/21 units/week, N (%)        8 (3.6)              12 (5.5)            8 (3.6)             14 (6.4)            0.438
  Smoking status, N (%)                                                                                                                  
   Current                                              54 (24.8)            49 (22.4)           44 (20.0)           30 (13.6)           
   Past                                                 124 (56.9)           122 (55.7)          121 (55.0)          128 (58.2)          
   Never                                                40 (18.4)            48 (21.9)           55 (25.0)           62 (28.2)           0.048
  Intake of fruit and vegetables ≥3 portions/d, N (%)   69 (31.4)            75 (34.1)           86 (39.1)           100 (45.5)          0.013
  Intake of fish ≥3 times/day, N (%)                    61 (27.7)            78 (35.5)           93 (42.5)           96 (43.8)           0.001
  Intake of fish oil supplement, N (%)                  57 (25.9)            50 (22.7)           75 (34.1)           69 (31.4)           0.035
  Physical activity, days/week, mean (SD)               3.6 (2.8)            5.1 (2.3)           5.3 (2.1)           5.7 (1.8)           \<0.001
  Participation in phase two cardiac rehabilitation‡    110 (50.2)           119 (54.1)          144 (65.5)          142 (64.8)          0.001

\*First quartile had the lowest MCS score; Fourth quartile had the highest MCS score.

†Totals may not sum to their respective totals due to missing data. No variable had more than 3.3% missing data.

‡Information collected 3 months after MI.

§Norm-based scoring (1998 US population) using weights derived from confirmatory factor analysis.

¶Information collected in the year before MI (in 2008).

\*\*Information collected at the time of MI.

††Redeemed prescription for at least two classes of antihypertensive drugs between MI and 180 days before.

‡‡Redeemed prescription for antidepressants between MI and 180 days before.

MRC, Medical Research Council; AT, angiotensin; HADS-A/D, Hospital Anxiety and Depression Scale-Anxiety/Depression; MCS, Mental Component Summary.

Cumulative incidence {#s3b}
--------------------

A total of 277 outcomes (230 new cardiovascular events and 47 deaths) occurred during 1940 person-years of follow-up (median 2.6 years, SD 1.0). The Kaplan-Meier curves ([figure 1](#BMJOPEN2013003045F1){ref-type="fig"}) show that the unadjusted risk of a cardiovascular event or death increased with decreasing mental health status. During the 3 years after MI, the cumulative incidence of the composite endpoint was 47.5% (95% CI 40.9% to 54.5%) for persons in the first quartile, 37.0% (30.9% to 43.9%) in the second quartile, 29.1% (23.5% to 35.6%) in the third quartile and 15.0% (10.8% to 20.5%) in the fourth quartile, p\<0.001.

![Kaplan-Meier curves by quartiles of mental health status (Mental Component Summary score from the Short-Form 12 V.2).](bmjopen2013003045f01){#BMJOPEN2013003045F1}

Association between mental health status and new cardiovascular events or death {#s3c}
-------------------------------------------------------------------------------

The age-adjusted HRs for new cardiovascular events or death in post-MI patients increased with decreasing mental health status (HR~3rd\ quartile~ 2.09 (95% CI 1.36 to 3.19), HR~2nd\ quartile~ 2.67 (1.77 to 4.03), HR~1st\ quartile~ 3.53 (2.36 to 5.27), [table 2](#BMJOPEN2013003045TB2){ref-type="table"}). Additional adjustment for cardiac disease severity, physical activity, depression and anxiety attenuated the association. In the fully adjusted model, the MI patients with the lowest mental health status had a more than twofold higher risk of new cardiovascular events or death compared to the patients with the highest mental health status ([table 2](#BMJOPEN2013003045TB2){ref-type="table"}).

###### 

Association between mental health status (Mental Component Summary score from the Short-Form 12 V.2) and subsequent cardiovascular events or death, with sequential adjustment for potential confounders

                                      HR (95% CI)                                                       
  ----------------------------------- --------------------- --------------------- --------------------- ---------------
  Age                                 3.53 (2.36 to 5.27)   2.67 (1.77 to 4.03)   2.09 (1.36 to 3.19)   1 (reference)
  Sociodemographic characteristics‡   3.56 (2.35 to 5.38)   2.57 (1.69 to 3.92)   2.06 (1.34 to 3.16)   1 (reference)
  MRC dyspnoea score ≥3               2.74 (1.76 to 4.26)   2.30 (1.50 to 3.53)   1.96 (1.27 to 3.00)   1 (reference)
  Comorbidity§                        2.65 (1.70 to 4.13)   2.29 (1.50 to 3.51)   1.99 (1.29 to 3.05)   1 (reference)
  Secondary prophylactic medication   2.77 (1.78 to 4.31)   2.32 (1.51 to 3.56)   1.95 (1.27 to2.99)    1 (reference)
  Smoking status                      2.76 (1.76 to 4.31)   2.31 (1.51 to 3.56)   1.96 (1.27 to 3.01)   1 (reference)
  Physical activity                   2.47 (1.56 to 3.91)   2.25 (1.47 to 3.46)   1.89 (1.23 to 2.91)   1 (reference)
  HADS-A/D score ≥8                   2.26 (1.37 to 3.73)   2.15 (1.38 to 3.35)   1.87 (1.21 to 2.88)   1 (reference)

\*Each model includes the variables from the preceding row so that the final model includes all the variables listed in this table.

†Number of outcomes/number of persons in quartile.

‡Sex, cohabitation status, education, labour market status.

§History of stroke, diabetes mellitus or heart failure.

MCS, Mental Component Summary; HADS-A/D, Hospital Anxiety and Depression Scale-Anxiety/Depression; MRC, Medical Research Council.

We found no statistically significant difference in HRs between any subgroups of MI patients ([figure 2](#BMJOPEN2013003045F2){ref-type="fig"}).

![Association between baseline mental health status (median cut) and subsequent cardiovascular events or death for patients with myocardial infarction and specific characteristics.](bmjopen2013003045f02){#BMJOPEN2013003045F2}

Exploratory analysis of the six mental health status items {#s3d}
----------------------------------------------------------

[Table 3](#BMJOPEN2013003045TB3){ref-type="table"} outlines the association between mental health status item scores and subsequent cardiovascular events or death. The items were entered as continuous variables and HRs reflect the risk of new cardiovascular events or death per one point lower item score. The largest HRs were seen for the 'Vitality' item, HR 1.24 (95% CI 1.09 to 1.42), the 'Mental Health' item 1, HR 1.19 (1.04 to 1.35), and the 'Role-Emotional' item 1, HR 1.16 (1.04 to 1.29).

###### 

Association between mental health status item scores (continuous; per one point lower item score) and subsequent cardiovascular events or death, with sequential adjustment for potential confounders and mediators

                                      HR (95% CI)                                                                                                   
  ----------------------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ---------------------
  Age                                 1.41 (1.27 to 1.56)   1.29 (1.18 to 1.41)   1.26 (1.15 to 1.37)   1.23 (1.12 to 1.35)   1.31 (1.18 to 1.46)   1.21 (1.09 to 1.35)
  Sociodemographic characteristics†   1.41 (1.26 to 1.57)   1.31 (1.19 to 1.43)   1.28 (1.17 to 1.41)   1.21 (1.10 to 1.34)   1.33 (1.19 to 1.48)   1.21 (1.08 to1.36)
  MRC dyspnoea score ≥3               1.30 (1.16 to 1.47)   1.21 (1.10 to 1.34)   1.18 (1.07 to 1.31)   1.12 (1.01 to 1.24)   1.24 (1.11 to 1.40)   1.11 (0.98 to 1.25)
  Comorbidity‡                        1.28 (1.14 to 1.44)   1.21 (1.09 to 1.33)   1.16 (1.05 to 1.28)   1.10 (0.99 to 1.22)   1.25 (1.11 to 1.40)   1.11 (0.98 to 1.25)
  Secondary prophylactic medication   1.31 (1.17 to 1.48)   1.22 (1.11 to 1.35)   1.18 (1.07 to 1.31)   1.12 (1.01 to 1.24)   1.24 (1.11 to 1.40)   1.11 (0.98 to 1.25)
  Smoking status                      1.31 (1.17 to 1.48)   1.22 (1.10 to 1.34)   1.18 (1.06 to 1.30)   1.12 (1.00 to 1.24)   1.25 (1.11 to 1.41)   1.11 (0.98 to 1.25)
  Physical activity                   1.27 (1.13 to 1.44)   1.18 (1.07 to 1.31)   1.14 (1.03 to 1.27)   1.08 (0.97 to 1.21)   1.22 (1.09 to 1.38)   1.07 (0.95 to 1.21)
  HADS-A/D score ≥8                   1.24 (1.09 to 1.42)   1.16 (1.04 to 1.29)   1.11 (0.99 to 1.24)   1.03 (0.91 to 1.16)   1.19 (1.04 to 1.35)   1.00 (0.87 to 1.16)

\*Each model includes the variables from the preceding row so that the final model includes all the variables listed in this table.

†Sex, cohabitation status, education, labour market status.

‡History of stroke, diabetes mellitus or heart failure.

HADS-A/D, Hospital Anxiety and Depression Scale-Anxiety/Depression; MRC, Medical Research Council.

Discussion {#s4}
==========

In this population-based cohort study, we found that low mental health status after first-time MI predicted an increased risk of new cardiovascular events or death in a dose--response manner. The association was explained partly by cardiac disease severity, physical activity, depression and anxiety. However, even after adjustments for these variables, patients with the lowest mental health status had a more than twofold higher risk of new cardiovascular events or death compared to those with the highest mental health status.

Strengths and limitations of the study {#s4a}
--------------------------------------

The major strengths of this study are its population-based nature and the homogeneous study population; we invited all patients with first-time MI during 1 year in a well-defined area. Our response rate was reasonably high (68.3%), and information on outcome was collected without loss to follow-up. Non-participants tended to have fewer social resources and more comorbid conditions, and hence they resembled the participants with the lowest mental health status. In order to address the potential risk of selection bias, we used antidepressant consumption as a proxy for depressive symptoms, similar to previous studies.[@R31] The estimates of the association between antidepressant consumption and new cardiovascular events or death in participants and non-participants were similar. Thus, bias due to selection of study participants seems to be an unlikely explanation for our findings.

Information on MI was registered prospectively and did not rely on the participants' or the relatives' memory. The MI diagnosis in the Danish National Patient Register was based on the current European Society of Cardiology criteria for MI, coded by the physician in charge of the discharge, and the information is known to have a high sensitivity (90%) and specificity (92%).[@R10] The specificity was even higher in our study because we confirmed the MI diagnosis by reviewing the discharge summaries,[@R9] and this reduced the risk of information bias. We also reduced the risk of information bias by using previously translated and validated scales, pilot testing the questionnaire among MI patients, and using high-quality register data.

We used a new algorithm for the calculation of the MCS score from the SF-12 V.2 using weights constructed by oblique confirmatory factor analysis, which allows the physical and mental component summary score to be correlated. Fleishman *et al*[@R15] developed this new scoring algorithm due to the controversy regarding the traditional scoring algorithm.[@R32; @R33; @R34] The traditional scoring algorithm forces mental and physical health to be uncorrelated. Consequently, when physical scores are well below the mean and mental scores somewhat less below the mean, as is often the case in patients with physical illness, this scoring method will result in an artefactual migration of the MCS score towards the mean.[@R32] In subanalyses, we estimated HRs based on traditionally computed MCS scores (see online supplementary table B). As expected, they were smaller compared to the HRs based on MCS scores computed with the new scoring algorithm. We evaluated mental health status 3 months after MI, allowing mental health to reach a more stable level after this major life event.

A diagnosis of depression or anxiety should ideally be based on a diagnostic interview. Since a previous study has estimated the sensitivity of the HADS-D≥8 for identification of depression to be 65% in MI patients,[@R19] a substantial number of participants with depression may have been misclassified as not having depression. However, we identified 18.3% with depression in our population (HADS-D≥8), which is in keeping with the prevalence of post-MI depression identified by structured clinical interviews in other studies (19.8%).[@R1] We found no studies reporting on the sensitivity and specificity of HADS-A in an MI population. However, among acute coronary syndrome patients, a HADS-A≥8 had a sensitivity of 91%.[@R21] Accordingly, we most likely identified the majority of patients with anxiety. In a sensitivity analysis, we excluded patients with depression or anxiety (HADS-A/D≥8), but this did not weaken the estimates (see online supplementary table C).

Schizophrenia and bipolar disorder are known to be associated with a higher risk of mortality, and part of this excess risk is attributable to cardiovascular diseases.[@R35] We used a prescription of antipsychotics, between MI and 180 days before, as an approximation of severe mental disorder. Thirteen participants had redeemed such a prescription. To examine how much of the association could be explained by these patients, we excluded this group in a sensitivity analysis (not shown), but this did not weaken the estimates.

Lifestyle behaviour was self-reported, and participants with low mental health status may have been more likely to under-report adverse lifestyle, including physical inactivity. However, participants with low mental health status did in fact report adverse lifestyle in our study, and a study on depression[@R36] found no differences when substituting self-reported physical activity with an objective measure of physical fitness.

Information on a range of participant characteristics and the large sample size allowed us to take into account several potential confounders, such as sociodemographic characteristics, cardiac disease severity, comorbidity and behavioural factors. In subanalyses, we adjusted for other potential confounders (body mass index, hypertension, history of depression, antidepressant use, intake of alcohol, fish and fruit, and participation in phase two cardiac rehabilitation), but this did not change the estimates (≤4%). However, we cannot rule out the possibility of residual confounding.

Comparison with other studies {#s4b}
-----------------------------

Four previous studies[@R5; @R6; @R7; @R8] have investigated the association between mental health status after MI and prognosis independent of various clinical risk factors, such as disease severity. They used different measures of mental health status (COOP charts,[@R6] Quality of Life after MI questionnaire,[@R8] the WHO Quality of Life Instrument Abbreviated[@R7] and SF-12[@R5]), and they all found an independent association between low mental health status and higher risk of adverse outcomes. Compared with our study, these studies were conducted in modest-sized cohorts (n=112,[@R6] 375,[@R8] 145[@R7]) and had short follow-up (4--5 months,[@R6] 18 months[@R8]); also, mental health status was assessed up to 5 years or more after MI[@R5] [@R7] and included only women[@R7] or patients who had an ejection fraction \<30%.[@R5] Most importantly, none of these four MI studies took into account important mediators such as depression, anxiety and potential behavioural mediators such as physical activity.

Our study is the first to explore the association between mental health status after MI and new cardiovascular events or death in subgroups, and we identified no factors that modified the risk. However, the sample size was low in some of the subgroups.

Our study is also the first to explore the association between mental health status and cardiovascular events or death on an item level. We found that the 'Vitality' item, the 'Role-Emotional' item 1, and the 'Mental Health' item 1 were significantly associated with adverse events after adjustments for clinical, sociodemographic, behavioural and other psychological risk factors, whereas the remaining items were not. Our results indicate that these items are the most important for the association between mental health status (MCS score) and adverse events. Yet, it is important to keep in mind that the items have different weights and that the physical items are also included when computing the MCS score.[@R12] [@R15]

Implications for clinicians {#s4c}
---------------------------

In addition to psychological, social and functional impairment, clinicians should be aware that low mental health status following MI is associated with an increased risk of new cardiovascular events and death. Our results underline the importance of always considering and prioritising mental health issues in postMI patients. In this study, we identified low mental health status after MI to be a significant risk factor for poor prognosis, independent of clinical, sociodemographic, behavioural and other psychological risk factors. In other words, mental health status has incremental value in the identification of patients at elevated risk for adverse outcome. Adding mental health status measurement to our present risk factor armamentarium could help clinicians to distinguish between groups of patients with a very low versus a very high risk of adverse outcome, and thereby help identify vulnerable patients in need of optimised care. However, we do not know whether measurement of mental health status and improved knowledge of prognosis will translate into better outcomes for our patients. This is an important focus for future research in this field.

Possible explanations and future research {#s4d}
-----------------------------------------

This study suggests that mental health status may capture prognostic aspects of mental health that are not captured by measures of depression and anxiety. Further research is needed to clarify more specifically what aspects of mental health are at play.

The underlying explanation for the association between mental health status after MI and new cardiovascular events or death remains unclear. Our study evaluated cardiac disease severity, behavioural factors and treatment strategies concurrently with mental health status. Therefore, we cannot determine whether these factors were the cause or the result of the mental health status. We were unable to assess whether the association was explained by biological mechanisms (such as heart rate variability, platelet function or inflammatory mechanisms) since we had no information on these biological variables. Future studies should incorporate such biological variables.[@R37]

Further research is also needed to identify interventions that can improve both mental health status and prognosis in MI patients. Murphy *et al*[@R38] examined the effectiveness of a complex intervention designed to improve outcomes, including mental health status (measured with SF-12) for patients with coronary heart disease in a cluster randomised controlled trial. The intervention was "tailored care plans for practices (practice based training in prescribing and behaviour change, administrative support, quarterly newsletter) and tailored care plans for patients (motivational interviewing, goal identification, and target setting for lifestyle change)."[@R38] They found that admissions to the hospital were significantly reduced after an intensive 18-month intervention to improve outcomes for patients with coronary heart disease, but there was no change in mental health status. It was not stated how they computed the MCS score, but they probably used the traditional scoring algorithm as the study was conducted prior to Fleishman\'s publication.[@R15] Hence, artefactual migration of the MCS score towards the mean in these physically ill participants may, at least in part, explain the lack of association.

Conclusion {#s5}
==========

We found that low mental health status following MI was associated with an increased risk of new cardiovascular events or death. The association was explained partly by cardiac disease severity, physical activity, depression and anxiety, but low mental health status remained an independent prognostic risk factor. Further research is needed to disentangle the pathways that link mental health status following MI to prognosis and, in continuation hereof, to identify interventions that can improve mental health status and prognosis.
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